FINNENCE ▪ THE WIRE FILE
THE WIRE · № 67709
Company■ Unclear/unknown
New Phase 3 trial: A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity — Novo Nordisk A/S
KINDCompany
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN2026-10-06 12:00 UTC
LAST UPDATE2026-10-06 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Novo's large cardiovascular-obesity outcomes trial could expand label use and defend its obesity franchise.
Novo obesity outcomes trial shapes franchise defense
CATALYST TO WATCH
Enrollment pace and future readout
MAIN RISK
Trial failure or competitor data
FULL DISPATCH
Sponsor: Novo Nordisk A/S; Status: Not Yet Recruiting; Conditions: Cardiovascular Risk, Obesity; Interventions: Zenagamtide, Placebo; Enrollment: 8500 (estimated); First posted: 2026-10-06; NCT: NCT07861100
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
New Phase 3 trial: Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury — Pharmazz, Inc.2026-10-06 12:00 UTC
New Phase 3 trial: Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury — Pharmazz, Inc.2026-10-06 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery — Vascular Therapies, Inc.2026-10-06 12:00 UTC
Phase 3 results posted: A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery — Vascular Therapies, Inc.2026-10-06 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Janssen Research & Development, LLC2026-10-06 12:00 UTC
Phase 3 results posted: A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Janssen Research & Development, LLC2026-10-06 12:00 UTC
→CORRELATIONshares Healthcare
Biobeat Brings Leading Hypertension Voices to AHA Hypertension Scientific Sessions as Conversation Shifts to Cuffless 24-Hour Ambulatory Blood Pressure Monitoring2026-10-06 17:24 UTC
Biobeat Brings Leading Hypertension Voices to AHA Hypertension Scientific Sessions as Conversation Shifts to Cuffless 24-Hour Ambulatory Blood Pressure Monitoring2026-10-06 17:24 UTC
→CORRELATIONshares Healthcare
InventHelp Inventor Develops HS Pain Relief Patch (MBQ-984)2026-10-06 17:30 UTC
InventHelp Inventor Develops HS Pain Relief Patch (MBQ-984)2026-10-06 17:30 UTC
→CORRELATIONshares Healthcare
HelloNation Article Featuring Eye Care Experts, Dr. R. Krishna Sanka and Dr. Singh, Examines Whether Reducing Glaucoma Eye Drops Can Improve Quality of Life2026-10-06 17:36 UTC
HelloNation Article Featuring Eye Care Experts, Dr. R. Krishna Sanka and Dr. Singh, Examines Whether Reducing Glaucoma Eye Drops Can Improve Quality of Life2026-10-06 17:36 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.